Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BIIB
BIIB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BIIB News
Biogen Acquires RayThera to Strengthen Immunology Business
4d ago
Fool
Biogen Acquires RayThera for $1 Billion to Boost Immunology Business
4d ago
Yahoo Finance
Biogen's Diversified Strategy and Investment Opportunities
5d ago
stocktwits
Investment Opportunities in Biotech Stocks
5d ago
CNBC
Biogen Warns of Q2 Financial Impact from Acquisitions
5d ago
seekingalpha
Software Stocks Rally as Moderna Surges 11% on Long-Term Strategy
Jun 26 2026
CNBC
Biogen Under Investigation for Securities Fraud Claims
Jun 23 2026
Globenewswire
NeOnc Secures Abu Dhabi IND Authorization for NEO212
Jun 22 2026
Newsfilter
Quantum BioPharma Advances MS Drug into Phase 2 Trials
Jun 22 2026
Globenewswire
Quantum BioPharma Advances New MS Drug Candidate Lucid-MS
Jun 22 2026
Newsfilter
Denali Sells Rare Pediatric Disease Priority Review Voucher for $195 Million
Jun 19 2026
NASDAQ.COM
Biotech Sector Sees FDA Approvals and Layoffs
Jun 19 2026
NASDAQ.COM
U.S. Stock Futures Rise as Investors Eye Four Key Stocks
Jun 18 2026
seekingalpha
Biogen Acquires RayThera to Expand Immunology Pipeline
Jun 18 2026
seekingalpha
Biogen Acquires RayThera for Up to $1 Billion
Jun 18 2026
NASDAQ.COM
Biogen Acquires RayThera to Enhance Immunology Pipeline
Jun 18 2026
stocktwits
Show More News
